Ferric carboxymaltose for treating iron deficiency anaemia

Published on 02 Sep 2019
Last Updated on 02 Jan 2024

Guidance Recommendations

The Ministry of Health's Drug Advisory Committee has recommended:

• Ferric carboxymaltose 500 mg/10 mL solution for injection/infusion for treating iron deficiency anaemia when oral iron preparations are ineffective or cannot be used.

Subsidy status

Ferric carboxymaltose 500 mg/10 mL solution for injection/infusion is recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indication.

SDL subsidy does not apply to ferric carboxymaltose 100 mg/2 mL injection.

Ferric carboxymaltose for iron deficiency anemia (Updated 2 Jan 2024) [PDF, 231 KB]

Ferric carboxymaltose for iron deficiency anaemia Plain English Summary (2 Sep 2019) [PDF, 33 KB]